| Stage | INFU | % of rev | SYK | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $37M | 100.00% | $6.5B | 100.00% | SYK ×176.54 |
| Gross profit | $21M | 57.98% | $4.2B | 65.15% | SYK +7.2pp |
| Operating income | $4M | 11.24% | $1.0B | 15.86% | SYK +4.6pp |
| Pre-tax income | $4M | 10.48% | $997M | 15.29% | SYK +4.8pp |
| Net income | $3M | 8.75% | $753M | 11.55% | SYK +2.8pp |
| Stage | INFU | SYK | Gap · A − B |
|---|---|---|---|
| Revenue | $37M100.00% | $6.5B100.00% | SYK ×176.54 |
| Gross profit | 57.98%$21M | 65.15%$4.2B | SYK +7.2pp |
| Operating income | 11.24%$4M | 15.86%$1.0B | SYK +4.6pp |
| Pre-tax income | 10.48%$4M | 15.29%$997M | SYK +4.8pp |
| Net income |
| 8.75%$3M |
| 11.55%$753M |
| SYK +2.8pp |
No shared counterparties.